EN
HI
Summary
As of 1 Sep, 2026, Windlas Biotech stock price is ₹1008.35. During the trading session, the stock has moved between an intraday low of ₹986.10 and an intraday high of ₹1015.95. Over the last 52 weeks, Windlas Biotech has traded between ₹697.40 and ₹1035.90.
The stock has recorded a trading volume of 45,866 shares, with a market capitalization of ₹20636229. Its Average Traded Price (ATP) is ₹1006.52, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1008.35.
Windlas Biotech has an upper circuit limit of ₹1193.00 and a lower circuit limit of ₹795.40. The total value traded stands at ₹4.62 CR, and the delivery percentage for the day is 50.14%.
The stock is currently traded with a market lot size of 1. Windlas Biotech also offers a dividend yield of 0.63%.
Windlas Biotech share price chart
Windlas Biotech Share Key Metrics
Volume
45866.00
Market Cap
2080.85 CR
LTQ@LTP
5@1008.35
ATP
1006.52
Var Margin
19.68 %
Circuit Range
795.4-1193
Delivery %
50.14 %
Value
4.62 CR
ASM/GSM
No
Market Lot
1
Windlas Biotech Fundamentals
P/E Ratio
30.86
P/B Ratio
3.99
Div. Yield
0.63
Sector P/E
41.23
Sector P/B
3.52
Sec. Div. Yield
0.51
Windlas Biotech Resistance and Support
Pivot 1001.4
Resistance
First Resistance
1012.8
Second Resistance
1031.4
Third Resistance
1042.8
Support
First Support
982.8
Second Support
971.4
Third Support
952.8
Windlas Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 01 2026 | 994.6 | 1008.35 | 1.42% | 1015.95 | 986.1 |
| Mon Aug 31 2026 | 998.54 | 994.2 | -0.43% | 1020 | 990 |
| Fri Aug 28 2026 | 990.34 | 998.54 | 1.15% | 1004.9 | 978.04 |
Windlas Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-04-17 | Buy Back of Shares |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Windlas Biotech News
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Windlas Biotech delivered strong Q1 FY27 results with revenue climbing 18% YoY to Rs 248 crore. Adjusted PAT surged 37% YoY to Rs 25 crore, reflecting robust operational performance.
Aug 10 2026 16:15:58
Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 10, 2026
Windlas Biotech reported Q1 FY27 revenue of ₹248.10 crore (up 18.09% YoY) and net profit of ₹17.65 crore. The company completed a ₹47 crore share buyback and approved a ₹6.30 per share dividend for FY26, also dissolving its US subsidiary, Windlas Inc.
Aug 10 2026 15:23:02
Windlas Biotech Management
| Name | Position |
|---|---|
| Ananta Narayan Panda | Company Secretary & Compliance Officer |
| Ashok Kumar Windlass | Whole Time Director |
Windlas Biotech Similar Stocks
Panacea Biotec Ltd.
390.90
3.80 (0.98%)
Sai Parenteral's Ltd.
518.75
-1.45 (0.28%)
Indoco Remedies Ltd.
243.84
0.50 (0.21%)
Venus Remedies Ltd.
1600.90
-62.70 (3.77%)
Hester Biosciences Ltd.
2200.50
-58.40 (2.59%)
Sakar Healthcare Ltd.
965.75
102.40 (11.86%)
Shukra Pharmaceuticals Ltd.
44.43
0.04 (0.09%)
Syncom Formulations (India) Ltd.
20.07
0.58 (2.98%)
Windlas Biotech FAQs
The Buying Price of Windlas Biotech share is 1008.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Windlas Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Windlas Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Windlas Biotech shares is 30.86. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Windlas Biotech shares is 3.99. Useful to assess the stock's value relative to its book value.
To assess Windlas Biotech’s valuation compare Sector P/E, P/B which are 41.23 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Windlas Biotech is 2080.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Windlas Biotech share price is 1035.90 & 697.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Windlas Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
